Zymeworks Inc. (ZYME) - Dilution Analysis

Visualizing historical and potential share dilution over time

Dilution Analysis

Medium Risk
Moderate dilution risk
Last updated: November 06, 2025

Risk Assessment Details

Potential Dilution: 0.0% of current shares
Recent Dilution: 10.91% (2 years)
Historical Dilution Factor: moderate recent dilution
Outstanding Shares
76M
Potential Supply
0
Additional shares possible
Splits
None
Past 2 years

Summary

ZYME currently has 75.8M outstanding shares. with minimal authorized share overhang for future dilution. The company has diluted shareholders by 10.91% over the past 2 years through share issuances.

Share Structure Timeline

Outstanding Shares
Total Supply

Historical Data Points

Date Event Outstanding Supply
Nov 06, 2025

10-Q filing | 75.8M shares outstanding

76M 0
Aug 07, 2025

10-Q filing | 75.3M shares outstanding

75M 0
May 08, 2025

10-Q filing | 75.2M shares outstanding

75M 0
Mar 05, 2025

10-K filing | 75.8M shares outstanding

76M 0
Oct 31, 2024

10-Q filing | 68.9M shares outstanding

69M 2.7M
Aug 01, 2024

10-Q filing | 76.4M shares outstanding

76M 0
May 02, 2024

10-Q filing | 76.2M shares outstanding

76M 0
Mar 06, 2024

10-K filing | 68.9M shares outstanding

69M 2.7M
Mar 06, 2024

S-3 filing: This S-3 filing relates to the potential disposition of up to 5,086,521 shares of common stock issuable upon the exercise of pre-funded warrants by selling stockholders.

71M 990K
Nov 07, 2023

10-Q filing | 70.6M shares outstanding

71M 0
Aug 10, 2023

10-Q filing | 67.3M shares outstanding

67M 0
May 08, 2023

10-Q filing | 66.7M shares outstanding

67M 0
Mar 07, 2023

10-K filing | 65.2M shares outstanding

65M 1.3M
Mar 07, 2023

POS AM filing: Zymeworks Inc. files a POS AM to register an offering of common stock, preferred stock, preferred stock purchase rights, debt securities, depositary shares, subscription rights and purchase contracts, with an aggregate offering price not to exceed $500,000,000. Shares of common stock having an aggregate offering price of up to $150,000,000 will be offered in an at-the-market offering through Cantor.

63M 3.4M
Nov 08, 2022

10-Q filing | 66.5M shares outstanding

66M 0
Oct 28, 2022

8-K filing: Zymeworks Inc. issued 1,375,000 shares of common stock upon the partial exercise of a warrant on October 25, 2022, and an additional 1,340,000 shares upon exercise of the remaining warrant portion on October 27, 2022, for a total exercise price of $271.50. ($0.0M proceeds)

N/A 0
Weekly Research

Get Weekly Super Stonk Alerts

Never miss a squeeze opportunity. Get our weekly analysis of high short interest stocks, AI-discovered gems, and dilution warnings delivered to your inbox.

No spam Unsubscribe anytime